Clinical Pharmacokinetics of Alcohol in A CDAT Sample Robert Cohen Consultant Addiction Psychiatrist 9.11.2012.

Slides:



Advertisements
Similar presentations
Instant Clinical Pharmacology E.J. Begg
Advertisements

Clinical Pharmacokinetics
PHARMACOKINETIC.
Late Stabilization & Maintenance Phase of Treatment.
Alcohol screening and brief intervention delivery to an Irish cohort of opiate dependent methadone maintained patients. Catherine Darker (PhD) Department.
Community Alcohol Detoxification Dr Merlin Willcox, Luther St Medical Centre, Oxford.
Poster will be available at after September 10 th 2006 ABSTRACT AN2690 is a new novel antifungal being developed for the treatment of onychomycosis.
Appraisal of Alcohol Withdrawal in Native Americans with the Clinical Institute Withdrawal Assessment of Alcohol Revised Scale. Paul Saladino MS, William.
Dennis M. Donovan, Ph.D., Michael P. Bogenschutz, M.D., Harold Perl, Ph.D., Alyssa Forcehimes, Ph.D., Bryon Adinoff, M.D., Raul Mandler, M.D., Neal Oden,
Module 4: Interaction of. Objectives To be aware of the possible reasons why dual diagnosis occurs To be aware of the specific effects of substances on.
Journal Club Alcohol and Health: Current Evidence July–August 2005.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence September-October 2007.
Pharmacokinetics of Drug Absorption
Pharmacokinetics Questions
Nonlinear pharmacokinetics
Starting a Business Conducting Start-up Market Research METHODS OF PRIMARY AND SECONDARY MARKET RESEARCH QUALITATIVE AND QUANTITATIVE RESEARCH SIZE AND.
Diagnosis And Treatment Of Prescription Opioid Dependence Steven W. Clay, D.O. Associate Professor, Department of Family Medicine Ohio University College.
How and Why Drugs Work Chapter 5
Practical Pharmacokinetics
Dose Adjustment in Renal and Hepatic Disease
Toxicokinetic Calculations
Gokaraju Rangaraju College of Pharmacy
INTRAVENOUS INFUSION.
Alcohol Physiology and Pharmacology
Chapter 3 Addictions: Theory and Treatment. Drug Addiction Behavioral pattern of drug use Overwhelming involvement Securing of its supply Tendency to.
Goldstein (1988) Gottesman & Shields (1966)
You have learned a LOT so far. A few extra facts to throw in No single reproducible abnormality in any NT, enzyme, receptor or gene has been found to.
Problems of Polypharmacy
Acute effects of alcohol on neural correlates of episodic memory encoding Hedvig Söderlund, Cheryl L. Grady, Craig Easdon and Endel Tulving Sundeep Bhullar.
An approach to maintenance Benzodiazepine prescribing Dr Malcolm Bruce Consultant Psychiatrist in Addiction NHS Lothian
Chapter 21 Alcohol. © Copyright 2005 Delmar Learning, a division of Thomson Learning, Inc.2 Chapter Objectives 1.Explain how alcoholic beverages are made.
1-Compartment Oral Dosing 400 mg of moxifloxacin is administered orally to Mr BB, a 68 yr old male who weighs 75 kg. Blood samples were drawn following.
Classification Of Psychiatric Disorders In Children And Adolescent
Normative misperceptions about alcohol use in the general population of drinkers Claire Garnett 1, David Crane 1, Robert West 2, Susan Michie 1, Jamie.
Table 1. Prediction model for maximum daily dose of buprenorphine-naloxone in a 12-week treatment condition Baseline Predictors Maximum Daily Dose Standardized.
Noncompartmental Models. Introduction The noncompartmental approach for data analysis does not require any specific compartmental model for the system.
Template provided by: “posters4research.com” Data were collected by interviewing the caseload holders at Services A and B with reference to patients case.
It May Only Be One Drink, but You Only Have One Life
Clinical Pharmacokinetics Fundamental hypothesis: a relationship exists between the pharmacological or toxic response to a drug and the accessible concentration.
1. Fate of drugs in the body 1.1 absorption 1.2 distribution - volume of distribution 1.3 elimination - clearance 2. The half-life and its uses 3. Repeated.
INTRODUCTION CLINICAL PHARMACOKINETICS
BIOPHARMACEUTICS.
Factors associated with concurrent Heroin use among patients on Methadone maintenance treatment in Vietnam from 2008 to 2013 Hoang Nam Thai MD, MPH – CDC/DGHT.
How and Why Drugs Work Chapter 5. Intended and Unintended Effects of Drugs Intended responses: - Reason for using the drug Unintended responses: - Side.
The DSM – how valid and reliable is it as a tool for diagnosis?
PHT 415 BASIC PHARMACOKINETICS
Time Plasma Conc (hr) (mg/L) Below limit of detection 1 Compartment IV Analysis & Renal Elimination 500 mg of tobramycin.
Objectives Compartment Modeling of Drugs Models describing drug concentration-time profiles Multi-compartment Models.
415 PHT Plasma Level – Time Curve
Learning objectives To know what data is available from pharmacokinetic studies in man and how to handle it To know how to calculate the basic pharmacokinetic.
London’s Mental Health Crisis Care Summit Workshop B: in the Emergency Department 25 th February 2016 Kia, Oval Dr Sean Cross and Dr Alex Thomson.
The Royal College of Emergency Medicine VTE Risk in Lower Limb Immobilisation in Plaster Cast Clinical Audit National findings The Royal College.
Drug Response Relationships
Compartmental Models and Volume of Distribution
Fibromyalgia Impact Questionnaire McGill Pain Questionnaire
David Sottile, Anthony DeFulio, and Kenneth Silverman INTRODUCTION
Quantitative Pharmacokinetics
The Best Alcohol Rehab Program
Chapter 6 Notes Part 1 Forensic toxicology.
Ethanol Toxicology Ethanol production Elimination
Clinical Pharmacokinetics
School of Pharmacy, University of Nizwa
Clinical Pharmacokinetics
Glucose Tolerance Test Physiology lab-3 February, 2018
School of Pharmacy, University of Nizwa
Therapeutic Drug Monitoring chapter 1 part 1
1-C: Renal and Hepatic Elimination
Introduction to Clinical Pharmacology Chapter 48 Urinary Tract Anti-Infectives and Other Urinary Drugs.
Forensic Toxicology Alcohol.
Presentation transcript:

Clinical Pharmacokinetics of Alcohol in A CDAT Sample Robert Cohen Consultant Addiction Psychiatrist

Introduction The way the body handles alcohol is of interest to a number of different groups

Back calculation of alcohol is based on the assumption that the body clears 1 unit of alcohol per hour (zero order kinetics) Zero order kinetics – same rate of removal however much alcohol left First order kinetics – the more alcohol in the blood stream, the quicker it is removed

Limited use of alcohol testing in the clinical setting Result of testing often limited to positive or negative –Though the readings in blood, breath and hair are quantitative and need interpretation

Alcohol testing Ethanol (ethyl alcohol) or metabolites can be tested in a variety of matrices –Blood –Breath –Sweat –Urine –Hair Breath alcohol levels closely parallel arterial blood levels Jones & Andersson, For Sci Int 2003;132: 18

The breathalyser Presents an easy method to test for alcohol levels Easy to carry out the test Reliable machinery

This study Kingston CDAT LDASS

The problem of interpreting breathalyser readings When you take a breathalyser reading, you do not know –When the person last drank –How much they drank But you may be able to gain an understanding if you know the rate of elimination, –which you can work out by taking multiple readings This study is a pilot into the start of this question

Methods 20 consecutive patients who attended for assessment for alcohol / drug problems and whose breathalyser reading was more than 0.00mg/l Breath alcohol level readings taken at regular intervals Rate of elimination calculated and compared to the concentration A composite made of all the readings

TimeBreath alcohol concentration (mg/l) 14:121.69

TimeBreath alcohol concentration (mg/l) 14: :271.55

TimeBreath alcohol concentration (mg/l) Rate of Elimination (mg/l/hr) 14: :271.55

TimeBreath alcohol concentration (mg/l) Rate of Elimination (mg/l/hr) 14: :

clearancedistributionabsorption

Results 20 patients at the time of audit 10 patients used only alcohol (‘alcoholics’) 10 patients used alcohol on top of methadone (‘drug addicts’) All met the criteria for a clinical ICD-10 diagnosis of mental and behavioural disorder due to use of alcohol, dependent type (F10.2)

Results - Demographics AlcoholicsDrug Addicts N10 Male5 (50%)8 (80%) Age – mean (range)50 (38-68)35.9 (26-44) Weekly units of alcohol – mean (range) (0-284)202.3 (56-455)

Results – Breathalyser Readings AlcoholicsDrug Addicts N10 Total # of readings3244 Range of number of readings per patient Readings (mg/l) Range - reduction rate (mg/l/hour) R for reduction rate & alcohol concentration 0.46 (p=0.007)0.43 (p=0.003)

All patients

Alcoholics Drug Addicts

Discussion - findings Alcohol clearance in people with the alcohol dependence syndrome appears to follow first order kinetics rather than zero order kinetics –This is a composite picture of 20 patients, rather than a full study of individuals over the whole of the pharmacokinetic profile (absorption, distribution and clearance) –This is therefore a pilot study, generating a hypothesis for formal testing

Discussion – clinical implications Potential to lead to biologically based diagnosis of alcohol dependence Biological support for drinking reduction as a therapeutic step prior to detoxification Possible clinical-biological difference between those only using alcohol and alcohol/opiate users

Discussion – clinical implications-1 If there are clinical differences in the pharmacokinetics of alcohol between dependent people and non-dependent people, this may form the basis of a clinical biologically based test for alcohol use disorder, as opposed to history / rating scale based diagnosis This is for future investigation

Discussion – clinical implications-2 This work may eventually elucidate the plasma level of alcohol associated with onset of withdrawal symptoms However, clinical observations of patients with low plasma levels (e.g., 0.10mg/l) is mixed –Some show withdrawal symptoms –Others do not

Discussion – clinical implications-2 If withdrawal symptoms drive alcohol consumption in dependent patients then more rapid clearance may be lead to greater consumption, thereby creating a vicious circle Helping people reduce consumption rather than attain immediate abstinence may therefore be an appropriate clinical goal as a step prior to detoxification Higher alcohol level Faster alcohol clearance Plasma reduction felt more Greater need to drink

Discussion – clinical implications-3 There may be a difference between those who are in addition opiate dependent and those who are only dependent on alcohol –There is some evidence for this (Clarke, JSAT 2006; 30:191) But the findings in this study may also be attributable to the higher level of drinking by opiate dependent patients

Thank you for listening